Pharmarsquo

Rediff.com » News » Pharmarsquo

News for Pharmarsquo

Business

Sun Pharmaceutical's vital signs: A strong dose of valuation multiples

Bolstered by an impressive performance in the global specialty business and outstanding results in the Indian market, Sun Pharmaceutical Industries, the largest pharmaceutical (pharma) company in......

Big pharma firms shift tack, look to bet on trade generics as volumes dip

Trade generic drugs (medicines that are sold directly through distributors) are fast becoming a key segment for domestic pharma firms as volume growth slows in the overall market. Image used for......

Fear of failure? Firms let IPO nods lapse on pricing mismatch, volatility

The initial public offering (IPO) market has seen some momentum of late with robust responses to recent issues. Illustration: Dominic Xavier/Rediff.com However, only some have been able to ride......

'Sun Pharma offers the best medium- to long-term earnings growth visibility'

India’s largest listed pharmaceutical (pharma) company — Sun Pharmaceutical Industries (Sun Pharma) — is expected to maintain its outperformance vis-à-vis the......

20-30% new products may be open to USFDA inspection

With all major US export-oriented drug manufacturing plants in the country up for inspection in 2022, some estimates peg that at least 20-30 per cent of the new product launches lined up for the US......

Rediff News

Pharmarsquo

News for Pharmarsquo

Sun Pharmaceutical's vital signs: A strong dose of valuation multiples

Big pharma firms shift tack, look to bet on trade generics as volumes dip

Fear of failure? Firms let IPO nods lapse on pricing mismatch, volatility

'Sun Pharma offers the best medium- to long-term earnings growth visibility'

20-30% new products may be open to USFDA inspection

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS